Business Wire

Welcome Home to Wellness: Delos Launches World’s First Residential Wellness Technology Platform

Del

Delos, the pioneer of wellness real estate and founder of the WELL Building Standard™, announced today the launch of the DARWIN Home Wellness Intelligence platform — a groundbreaking offering designed to enhance health outcomes in the home and mitigate harmful indoor environmental concerns, utilizing Delos’ proprietary wellness algorithms and sensor technologies, to create spaces that help reduce stress, improve sleep quality, increase performance and enhance overall well-being.

“Despite most of human history spent outside, we now spend nearly 90% of our time indoors, and yet rarely focus on the impact the indoor environment can have on our health and well-being. Through extensive scientific research and real-world testing, we discovered that we can mitigate environmental triggers within our homes to enhance both physical and emotional well-being,” said Delos Chief Executive Officer and Founder Paul Scialla. “Delos’ DARWIN platform incorporates health and wellness features and technologies into the home to bring the benefits of natural outdoor conditions inside. We are excited to work with our global partners to introduce a new era of wellness technology into homes.”

Backed by over seven years of research, the DARWIN Home Wellness Intelligence platform focuses on four main components: air filtration, water purification, circadian lighting and comfort-focused technologies, all of which simulate the natural outdoor condition. Powered by Delos’ proprietary cloud-based algorithms, the dynamic platform interacts with an ecosystem of Delos approved products and solutions to bring wellness intelligence into the connected home environment. DARWIN is flexible and accessible, launching across all segments of the housing market, from mass market to luxury.

Delos is partnering with premier dealers, installers, builders and other stakeholders across the globe to integrate the DARWIN Home Wellness Intelligence platform into residences:

  • HTSA Network: Delos is training professionals throughout the United States to become accredited DARWIN dealers and installers.
  • Simonds Homes: Simonds, a leading volume home builder in Australia, will include DARWIN as part of its base package in all new homes in the state of Victoria beginning this month, setting a new baseline for market rate housing.
  • KB Home: Delos is a title sponsor for the KB “Home of Future”, scheduled to be unveiled at the 2019 Consumer Electronics Show in Las Vegas. DARWIN will be featured as the home’s wellness technology platform.
  • Lateral Estate: Lateral, a preeminent Australian real estate developer, has announced DARWIN as a standard offering in all of its multi-family residences at Parc Blakehurst in Sydney.
  • 1371 Summitridge Drive, 521 North Cannon Drive: As part of a broad national roll out in luxury housing, these luxury single family homes in Beverly Hills, California incorporate the comprehensive home wellness platform, making them the first luxury residences to be powered by DARWIN. DARWIN is currently being commissioned by many of the most sought after newly constructed luxury homes in the United States.

“For years, the value proposition of smart technology in the home has been elusive for the masses,” said Delos Chief Technology Officer Jim Hunter. “These technologies have primarily focused on security, energy, convenience and entertainment. However, it is the health and well-being of the ones we love that is most valuable. Born out of extensive research, DARWIN is the delivery platform for our wellness algorithms that helps improve the environmental conditions where we live, work, sleep and play."

Delos has fostered leading research collaborations with the Cleveland Clinic, Mayo Clinic, a board of doctors from the Columbia University Medical Center and architects, scientists and wellness thought leaders to introduce wellness standards, programs and solutions into the built environment. Delos established the Well Living Lab™ in collaboration with Mayo Clinic — the world’s first lab committed to researching the real-world impacts of the indoor environment on human health and performance. Delos’ wellness technologies and solutions, along with the International WELL Building Institute’s WELL Building Standard, have seen broad adoption of wellness real estate programs across the commercial real estate market, with nearly 1,000 projects in 35 countries. Building upon the substantial success in the commercial sector, the launch of the DARWIN Home Wellness Intelligence platform marks the first expansion of Delos’ offerings to the residential smart-home market.

“Our home environment has a profound impact on our health, well-being and happiness. As the pioneer of wellness real estate and the founder of the WELL Building Standard, the introduction of the DARWIN Home Wellness Intelligence platform is a natural extension of Delos’ leading science and research and makes improved health, well-being and happiness available to all," said Deepak Chopra (Delos Advisory Board Member).

About Delos

Delos is a wellness real estate and technology company that is transforming the lives of people around the world by creating residential and commercial spaces designed to improve health, well-being and performance. Informed by seven years of research and rigorous analysis of environmental health impacts on people, Delos and its affiliates offer an array of innovative technology, consulting and design solutions for residential and commercial spaces. Delos’ wholly-owned subsidiary, the International WELL Building Institute pbc, delivers the WELL Building Standard™, the premier standard for buildings, interior spaces and communities seeking to implement, validate and measure features that support and advance human health and wellness. Delos’ advisory board is comprised of leading professionals across real estate, government policy, medicine and sustainability, including renowned wellness luminary Deepak Chopra and sustainability advocate Leonardo DiCaprio. For more information about Delos, please visit www.delos.com.

Contact information

Weber Shandwick for Delos
Amelise Lane, 212-546-7830
alane@webershandwick.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Hilton Launches New Brand, Signia Hilton, Delivering Sophisticated Travel While Reimagining Meetings and Events22.2.2019 17:00:00Pressemelding

Hilton (NYSE: HLT) today announced the launch of Signia Hilton, its dynamic, new meetings-and-events-focused brand. The portfolio of hotels is setting out to transform the industry for meeting professionals and sophisticated business travelers by infusing state-of-the-art technology and design into every aspect of the guest experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005071/en/ The brand further reinforces Hilton’s commitment to innovation that meets the evolving needs of today’s travelers and will bring premium experiences to top urban and resort destinations around the world. “In our 100th year of hospitality, we are more focused than ever on providing exceptional experiences to all of our guests – and that includes evolving those experiences to meet their changing needs,” said Christopher J. Nassetta, president and CEO, Hilton. “We are proud to launch Signia Hilton, which exemplifies our innovative sp

Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans22.2.2019 16:30:00Pressemelding

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, announced today that it has received CE mark approval for 1.5T and 3T full-body magnetic resonance imaging (“MRI”) conditional labeling for the Axonics r-SNM® System. The Axonics r-SNM System is the only implantable SNM system that has received full-body MRI conditional labeling for sale in Europe1. Raymond W. Cohen, Chief Executive Officer of Axonics, said, “Without this labeling, any patient requiring an MRI scan on any body part below the head must have their neurostimulator surgically explanted prior to the MRI scan, resulting in an additional surgery for the patient and additional costs to patients and the healthcare system. This authorization of full-body MRI scans in Europe is another important milestone for Axonics, differentiating our te

Fantastec Joins Forces with Arsenal FC Launching Official Blockchain Collectibles App22.2.2019 14:30:00Pressemelding

Fantastec announced today its first football licensing agreement with Premier League club Arsenal FC for a new blockchain authenticated collectibles app called Fantastec SWAP. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005277/en/ Arsenal players appear on Fantastec SWAP in official licensing deal (Graphic: Business Wire) London-based Fantastec is a leading sports fan technology innovator, and its blockchain based ‘SWAP’ app will have broad appeal to global sports fans, gamers and sports card collectors alike. Fantastec SWAP unlocks unique and authentic club content through the app, like player autographs and exclusive footage. With its innovative blockchain technology, fans around the world can now discover, collect and swap officially licensed club collectibles with other fans with complete trust. “Fantastec SWAP is a game-changer for international football fans as well the sports collectibles industry,” commented

Volkswagen Protects Virtual Key Sharing App with Trustonic Application Protection22.2.2019 13:42:00Pressemelding

Volkswagen is working with mobile cyber security leader Trustonic to enable customers to use smartphones to access their vehicles, and to securely share their digital car keys to grant access to others via a smartphone app. Volkswagen is using the Trustonic Application Protection (TAP) platform to secure the mobile app and ensure that sensitive information and key transfer requests are securely displayed to, and approved by, a real authenticated user on a trusted device and not by hackers or malware simulating a user or device. “The smartphone is becoming the vehicle key of the future and our We Connect service is the interface for this today in the new Volkswagen Passat,” comments Alf Pollex, Head of Infotainment and Connected Car at Volkswagen AG. “The user installs the We Connect app on their smartphone which is then authorized via the infotainment system with a Transaction Number. The Mobile Key will be compatible with Android-based Samsung devices. No mobile network connection is

Mundipharma EDO GmbH: US FDA grants Orphan Drug Designation for etoposide toniribate in relapsed/refractory biliary tract cancer22.2.2019 13:30:00Pressemelding

Mundipharma EDO GmbH, part of the Mundipharma network of independent associated companies, and Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., today announced that the US FDA has granted Orphan Drug Designation (ODD) to etoposide toniribate for the treatment of relapsed/refractory biliary tract cancer, also known as cholangiocarcinoma.3 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005126/en/ Biliary tract cancer is a rare tumour with approximately 8,000 patients diagnosed in the US every year and 10,571 in Europe.4,5 The FDA grants ODD status to medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US. Radical surgery is the only curative treatment for biliary tract cancer but, in most cases, the cancer is inoperable. Patients who fail first-line chemotherapy have limited treatment options and the standard of

Lenovo Data Center Group Delivers Broad Edge Computing Portfolio, Expands Investments in IoT22.2.2019 13:13:00Pressemelding

Next week at MWC Barcelona, Lenovo Data Center Group (DCG) will showcase continued investments in its solutions supporting IoT and edge computing as part of its IoT growth plan over the next few years. Building on the momentum of its fifth consecutive quarter of profit growth, Lenovo DCG is building a portfolio that takes infrastructure to where the data is, whether that be in the traditional data center, in the cloud or increasingly, at the edge. Today, around 10 percent of enterprise-generated data is created and processed outside a traditional centralized data center or cloud. By 2022, Gartner predicts this figure will reach 75 percent. This migration is driving increased concerns around data privacy, security and regulations coupled with challenges of latency, bandwidth and downtime. Lenovo is addressing these challenges by creating a broad portfolio of edge computing offerings that address the different ways that customers want to deploy edge computing solutions for IoT use cases.